PDF(Sci-hub)
Abstract：
This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use.
A comprehensive literature search was conducted from January 1, 2010, to March 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, Cochrane, Agency for Healthcare Research and Quality Reports, and other selected database relevant to this guideline.
Many recommendations from the earlier valvular heart disease guidelines have been updated with new evidence and provides newer options for diagnosis and treatment of valvular heart disease. This summary includes only the recommendations from the full guideline which focus on diagnostic work-up, the timing and choice of surgical and catheter interventions, and recommendations for medical therapy. The reader is referred to the full guideline for graphical flow charts, text, and tables with additional details about the rationale for and implementation of each recommendation, and the evidence tables detailing the data considered in developing these guidelines.
A comprehensive literature search was conducted from January 1, 2010, to March 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, Cochrane, Agency for Healthcare Research and Quality Reports, and other selected database relevant to this guideline.
Many recommendations from the earlier valvular heart disease guidelines have been updated with new evidence and provides newer options for diagnosis and treatment of valvular heart disease. This summary includes only the recommendations from the full guideline which focus on diagnostic work-up, the timing and choice of surgical and catheter interventions, and recommendations for medical therapy. The reader is referred to the full guideline for graphical flow charts, text, and tables with additional details about the rationale for and implementation of each recommendation, and the evidence tables detailing the data considered in developing these guidelines.
摘要：
瓣膜性心脏病指南的执行摘要为临床医生诊断和管理瓣膜性心脏病提供了建议，并提供了支持文档以鼓励其使用。
从2010年1月1日至2020年3月1日进行了全面的文献检索，包括研究，reviews,以及PubMed以英文发表的关于人类受试者的其他证据，EMBASE,科克伦,医疗保健研究和质量报告机构，以及与本指南相关的其他选定数据库。
早期瓣膜性心脏病指南的许多建议已经更新，并提供了新的证据，为瓣膜性心脏病的诊断和治疗提供了新的选择。本摘要仅包括完整指南中的建议，这些建议侧重于诊断工作，手术和导管介入的时机和选择，以及药物治疗的建议。读者可以参考图形流程图的完整指南，文本,以及关于每一项建议的理由和执行情况的更多细节的表格，以及详细说明在制定这些指南时考虑的数据的证据表。
从2010年1月1日至2020年3月1日进行了全面的文献检索，包括研究，reviews,以及PubMed以英文发表的关于人类受试者的其他证据，EMBASE,科克伦,医疗保健研究和质量报告机构，以及与本指南相关的其他选定数据库。
早期瓣膜性心脏病指南的许多建议已经更新，并提供了新的证据，为瓣膜性心脏病的诊断和治疗提供了新的选择。本摘要仅包括完整指南中的建议，这些建议侧重于诊断工作，手术和导管介入的时机和选择，以及药物治疗的建议。读者可以参考图形流程图的完整指南，文本,以及关于每一项建议的理由和执行情况的更多细节的表格，以及详细说明在制定这些指南时考虑的数据的证据表。
